PKU and Living Medicines: Spotlight Synlogic  
https://pixabay.com/en/seattle-washington-city-state-3465797/

PKU and Living Medicines: Spotlight Synlogic  

Press releases earlier this year on biotech company, Synlogic, announced quite favorable results on both pre-clinical and clinical data on a unique application of synthetic biology for the rare disease, phenylketonuria (PKU). In just…

Continue Reading PKU and Living Medicines: Spotlight Synlogic  
“Many Faces of NF”: Artist Highlights Tumor-Causing Genetic Disorder
mcmurryjulie / Pixabay

“Many Faces of NF”: Artist Highlights Tumor-Causing Genetic Disorder

If you haven't heard of neurofibromatosis (NF), you’re in surprisingly good company. For most of her life, Rachel Mindrup, an artist, illustrator, and Resident Assistant Professor at Creighton University, who…

Continue Reading “Many Faces of NF”: Artist Highlights Tumor-Causing Genetic Disorder

This Week at the FDA: A Win For a Potential Pancreatic Cancer and Narcolepsy Treatments and a New List of Pediatric Cancer Targets

Happy Friday everyone! The leaves are beginning to change, and so are ongoing activities at the FDA. This week, we're highlighting four FDA announcements we think you should  hear about.…

Continue Reading This Week at the FDA: A Win For a Potential Pancreatic Cancer and Narcolepsy Treatments and a New List of Pediatric Cancer Targets